- Report
- April 2024
- 104 Pages
Global
From €4374EUR$4,950USD£3,854GBP
- Report
- January 2024
- 68 Pages
Asia Pacific
From €2607EUR$2,950USD£2,297GBP
- Report
- May 2023
- 201 Pages
Global
From €2430EUR$2,750USD£2,141GBP
€4860EUR$5,500USD£4,282GBP
- Report
- January 2021
Global
From €2209EUR$2,500USD£1,946GBP
€4418EUR$5,000USD£3,893GBP
- Report
- December 2023
- 365 Pages
Global
From €2784EUR$3,150USD£2,452GBP
€3711EUR$4,200USD£3,270GBP
- Report
- June 2022
- 358 Pages
Global
From €2320EUR$2,625USD£2,044GBP
€3093EUR$3,500USD£2,725GBP
- Report
- December 2024
- 403 Pages
Global
From €4374EUR$4,950USD£3,854GBP
- Report
- September 2025
- 82 Pages
China
From €4109EUR$4,650USD£3,620GBP
- Report
- December 2024
- 168 Pages
Global
From €4109EUR$4,650USD£3,620GBP
- Report
- November 2024
- 84 Pages
Global
From €4109EUR$4,650USD£3,620GBP
- Report
- September 2024
- 166 Pages
Global
From €4109EUR$4,650USD£3,620GBP
- Report
- August 2024
- 112 Pages
Global
From €4109EUR$4,650USD£3,620GBP
- Report
- February 2024
- 442 Pages
Global
From €4109EUR$4,650USD£3,620GBP
- Report
- January 2024
- 492 Pages
Global
From €4109EUR$4,650USD£3,620GBP
- Report
- December 2023
- 192 Pages
Global
From €4109EUR$4,650USD£3,620GBP
- Report
- October 2023
- 154 Pages
Global
From €4109EUR$4,650USD£3,620GBP
- Report
- July 2023
- 200 Pages
Global
From €4109EUR$4,650USD£3,620GBP
- Report
- March 2023
- 164 Pages
Global
From €2209EUR$2,500USD£1,946GBP
- Report
- October 2022
- 147 Pages
Global
From €4860EUR$5,500USD£4,282GBP
- Report
- February 2022
- 312 Pages
Global
From €2651EUR$3,000USD£2,336GBP

The Next Generation Sequencing (NGS) market is a subset of the biotechnology industry that focuses on the development and application of high-throughput sequencing technologies. NGS technologies enable the rapid and cost-effective sequencing of large amounts of DNA or RNA, allowing for the analysis of genetic variation and gene expression. This technology has been used to identify and characterize genetic mutations, to study gene expression, and to develop new diagnostics and therapeutics. NGS has also been used to study the evolution of viruses and bacteria, and to identify new species.
The NGS market is highly competitive, with a number of companies offering a range of sequencing technologies and services. Some of the major players in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more